The new pens will eventually be phased in to replace NovoPen 5 and NovoPen Echo in countries where those devices are already available. Last year Glooko and Novo Nordisk launched the ...

Novo Nordisk has made its smart insulin ... The new devices – NovoPen 6 and NovoPen Echo Plus – are insulin self-injection pens that record information such as when and how much insulin ...

The European Medicines Agency warned about pre-filled pens falsely labeled as Novo Nordisk A/S's (NYSE: NVO) popular diabetes drug Ozempic at wholesalers in the European Union and the U.K. The ...

Ozempic maker Novo Nordisk on Wednesday said data showed its hotly anticipated weight loss pill prompts greater and more rapid weight loss than its blockbuster treatment Wegovy, amid competition ...

The company is a contractor that does fill-finish work - involving the filling and packaging of syringes and injection pens in sterile ... Danish pharma major Novo Nordisk's (NOVOb.CO), opens ...

Update: Adds company statement about Ozempic availability in the U.S. Novo Nordisk (NVO ... including the 0.25/0.5 mg, 1 mg and 2mg pens of Ozempic for patients with type 2 diabetes, the company ...

Sept 17 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of price negotiations ...

With so many high protein products available, some of the Liverpool ECHO team decided to put the Novo Protein Pops to the test. Five of the flavours have 10g of protein, whereas the tangy cheese ...

DSV A/S’s new acquisition, the $15.9 billion takeover of DB Schenker, will almost double the freight company’s sales, making it Denmark’s second-largest firm by that measure and pushing Novo ...

Novo Nordisk A/S’s Wegovy reduced deaths and illness from Covid in a large study that took place during the pandemic, more evidence of the blockbuster shot’s benefits beyond weight loss.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity ...